Home Journal Club FAQ My Amedeo About Tranquillis Services Flying Publisher   

Books, Journals, Podcasts, Weekly Updates,
by Amedeo

  Liver Cirrhosis

  Free Subscription


Articles published in Hepatology

Retrieve available abstracts of 223 articles:
HTML format
Text format



Single Articles


    March 2010
  1. SOBREVALS L , Rodriguez C, Romero-Trevejo JL, Gondi G, et al
    Insulin-like growth factor I gene transfer to cirrhotic liver induces fibrolysis and reduces fibrogenesis leading to cirrhosis reversion in rats.
    Hepatology. 2010;51:912-21.
    PubMed     Text format     Related articles    Abstract available


  2. LIN WR , Lim SN, McDonald SA, Graham T, et al
    The histogenesis of regenerative nodules in human liver cirrhosis.
    Hepatology. 2010;51:1017-26.
    PubMed     Text format     Related articles    Abstract available


    February 2010
  3. LENOS MG , Tsaniklidou SM
    Comment on "Angiotensin-converting-enzyme 2 inhibits liver fibrosis in mice".
    Hepatology. 2010;51:718.
    PubMed     Text format     Related articles   


  4. ADAMS L
    Transient elastography in nonalcoholic fatty liver disease: making sense of echoes.
    Hepatology. 2010;51:370-2.
    PubMed     Text format     Related articles   


    January 2010
  5. BRUNO S , Crosignani A, Facciotto C, Rossi S, et al
    Sustained virologic response prevents the development of esophageal varices in compensated, child-pugh class a hepatitis C virus-induced cirrhosis. A 12-year prospective follow-up study.
    Hepatology. 2010.
    PubMed     Text format     Related articles    Abstract available


  6. BOYER TD
    Tolvaptan and hyponatremia in a patient with cirrhosis.
    Hepatology. 2010;51:699-702.
    PubMed     Text format     Related articles   


    December 2009
  7. ALISI A , Pinzani M, Nobili V
    Diagnostic power of fibroscan in predicting liver fibrosis in nonalcoholic fatty liver disease.
    Hepatology. 2009;50:2048-9.
    PubMed     Text format     Related articles   


  8. CHOI SS , Diehl AM
    Epithelial-to-mesenchymal transitions in the liver.
    Hepatology. 2009;50:2007-13.
    PubMed     Text format     Related articles    Abstract available


    November 2009
  9. GARCIA-TSAO G , Friedman S, Iredale J, Pinzani M, et al
    Now there are many (stages) where before there was one: In search of a pathophysiological classification of cirrhosis.
    Hepatology. 2009.
    PubMed     Text format     Related articles   


  10. APPENRODT B , Grunhage F, Gentemann MG, Thyssen L, et al
    Nucleotide-binding oligomerization domain containing 2 (NOD2) variants are genetic risk factors for death and spontaneous bacterial peritonitis in liver cirrhosis.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available


  11. SHIMODA S , Harada K, Niiro H, Taketomi A, et al
    CX3CL1 (fractalkine): A signpost for biliary inflammation in primary biliary cirrhosis.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available


  12. HIRSCHFIELD GM , Siminovitch KA
    Toward the molecular dissection of primary biliary cirrhosis.
    Hepatology. 2009;50:1347-50.
    PubMed     Text format     Related articles   


    October 2009
  13. CARRION JA , Torres F, Crespo G, Miquel R, et al
    Liver stiffness identifies two different patterns of fibrosis progression in patients with hepatitis C virus recurrence after liver transplantation.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available


  14. SHAWCROSS DL , Shabbir SS, Taylor NJ, Hughes RD, et al
    Ammonia and the neutrophil in the pathogenesis of hepatic encephalopathy in cirrhosis.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available


  15. QUAGLIA A , Mustafa A, Mitry RR, Portmann B, et al
    Image of the month. Copper-metallothionein autofluorescence.
    Hepatology. 2009;50:1312-3.
    PubMed     Text format     Related articles   


  16. POPOV Y , Schuppan D
    Targeting liver fibrosis: strategies for development and validation of antifibrotic therapies.
    Hepatology. 2009;50:1294-306.
    PubMed     Text format     Related articles    Abstract available


  17. SRIPA B , Mairiang E, Thinkhamrop B, Laha T, et al
    Advanced periductal fibrosis from infection with the carcinogenic human liver fluke Opisthorchis viverrini correlates with elevated levels of interleukin-6.
    Hepatology. 2009;50:1273-81.
    PubMed     Text format     Related articles    Abstract available


    September 2009
  18. BRUNO S , Shiffman ML, Roberts SK, Gane EJ, et al
    Efficacy and safety of peginterferon alfa-2a (40KD) plus ribavirin in hepatitis C patients with advanced fibrosis and cirrhosis.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available


  19. EVERHART JE , Wright EC, Goodman ZD, Dienstag JL, et al
    Prognostic value of Ishak fibrosis stage: Findings from the hepatitis C antiviral long-term treatment against cirrhosis trial.
    Hepatology. 2009;51:585-594.
    PubMed     Text format     Related articles    Abstract available


  20. NAZAR A , Pereira GH, Guevara M, Martin-Llahi M, et al
    Predictors of response to therapy with terlipressin and albumin in patients with cirrhosis and type 1 hepatorenal syndrome.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available


  21. MODI AA , Feld JJ, Park Y, Kleiner DE, et al
    Increased caffeine consumption is associated with reduced hepatic fibrosis.
    Hepatology. 2009;51:201-209.
    PubMed     Text format     Related articles    Abstract available


  22. RODERFELD M , Rath T, Voswinckel R, Dierkes C, et al
    Bone marrow transplantation demonstrates medullar origin of CD34(+) fibrocytes and ameliorates hepatic fibrosis in Abcb4(-/-) mice.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available


  23. WONG VW , Vergniol J, Wong GL, Foucher J, et al
    Diagnosis of fibrosis and cirrhosis using liver stiffness measurement in nonalcoholic fatty liver disease.
    Hepatology. 2009;51:454-462.
    PubMed     Text format     Related articles    Abstract available


  24. RATZIU V , Charlotte F, Bernhardt C, Giral P, et al
    Long-term efficacy of rosiglitazone in nonalcoholic steatohepatitis: Results of the fatty liver improvement by rosiglitazone therapy (FLIRT 2) extension trial.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available


  25. OSTERREICHER CH , Taura K, De Minicis S, Seki E, et al
    Angiotensin-converting-enzyme 2 inhibits liver fibrosis in mice.
    Hepatology. 2009;50:929-38.
    PubMed     Text format     Related articles    Abstract available


  26. MARRA F , Bertolani C
    Adipokines in liver diseases.
    Hepatology. 2009;50:957-69.
    PubMed     Text format     Related articles    Abstract available


    August 2009
  27. RUNYON BA
    Management of adult patients with ascites due to cirrhosis: An update.
    Hepatology. 2009;50:1321.
    PubMed     Text format     Related articles   


  28. PLESSIER A , Darwish-Murad S, Hernandez-Guerra M, Consigny Y, et al
    Acute portal vein thrombosis unrelated to cirrhosis: A prospective multicenter follow-up study.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available


  29. GUSTOT T , Durand F, Lebrec D, Vincent JL, et al
    Severe sepsis in cirrhosis.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available


  30. OSAWA Y , Seki E, Adachi M, Suetsugu A, et al
    Role of acid sphingomyelinase of Kupffer cells in cholestatic liver injury in mice.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available


  31. KAKAZU E , Ueno Y, Kondo Y, Fukushima K, et al
    Branched chain amino acids enhance the maturation and function of myeloid dendritic cells ex vivo in patients with advanced cirrhosis.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available


  32. PRADAT P , Trepo E, Potthoff A, Bakshi R, et al
    The cirrhosis risk score predicts liver fibrosis progression in patients with initially mild chronic hepatitis C.
    Hepatology. 2009.
    PubMed     Text format     Related articles   


  33. TREBICKA J , Hennenberg M, Schulze Probsting A, Laleman W, et al
    Role of beta(3)-adrenoceptors for intrahepatic resistance and portal hypertension in liver cirrhosis.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available


  34. MORENO-OTERO R , Trapero-Marugan M
    Extrahepatic conditions associated with primary biliary cirrhosis.
    Hepatology. 2009.
    PubMed     Text format     Related articles   


  35. MORITOKI Y , Lian ZX, Lindor K, Tuscano J, et al
    B-cell depletion with anti-CD20 ameliorates autoimmune cholangitis but exacerbates colitis in transforming growth factor-beta receptor II dominant negative mice.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available


  36. BAJAJ JS , Wade JB, Sanyal AJ
    Spectrum of neurocognitive impairment in cirrhosis: Implications for the assessment of hepatic encephalopathy.
    Hepatology. 2009.
    PubMed     Text format     Related articles   


  37. MYERS RP , Shaheen AA, Fong A, Burak KW, et al
    Epidemiology and natural history of primary biliary cirrhosis in a Canadian health region: A population-based study.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available


  38. GOODMAN ZD , Stoddard AM, Bonkovsky HL, Fontana RJ, et al
    Fibrosis progression in chronic hepatitis C: Morphometric image analysis in the HALT-C trial.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available


  39. QI X , Han G, Fan D
    The preferable treatment for cirrhotic portal vein thrombosis: Anticoagulation or transjugular intrahepatic portosystemic shunt?
    Hepatology. 2009;51:713-714.
    PubMed     Text format     Related articles   


  40. ARROYO V
    Human serum albumin: not just a plasma volume expander.
    Hepatology. 2009;50:355-7.
    PubMed     Text format     Related articles   


  41. BOURSIER J , Cales P
    Combination of fibrosis tests: sequential or synchronous?
    Hepatology. 2009;50:656-7.
    PubMed     Text format     Related articles   


    July 2009
  42. ZHONG W , Shen WF, Ning BF, Hu PF, et al
    Inhibition of extracellular signal-regulated kinase 1 by adenovirus mediated small interfering RNA attenuates hepatic fibrosis in rats.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available


  43. N'KONTCHOU G , Mahamoudi A, Aout M, Ganne-Carrie N, et al
    Radiofrequency ablation of hepatocellular carcinoma: Long-term results and prognostic factors in 235 Western patients with cirrhosis.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available


  44. NAHON P , Sutton A, Rufat P, Ziol M, et al
    Myeloperoxidase and superoxide dismutase 2 polymorphisms comodulate the risk of hepatocellular carcinoma and death in alcoholic cirrhosis.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available


  45. SON G , Hines IN, Lindquist J, Schrum LW, et al
    Inhibition of phosphatidylinositol 3-kinase signaling in hepatic stellate cells blocks the progression of hepatic fibrosis.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available


  46. RASHID M , Mitchell JD, Cramp ME, Cross TJ, et al
    Limitations of the algorithm for the SAFE biopsy: A noninvasive fibrosis measure in chronic hepatitis C.
    Hepatology. 2009.
    PubMed     Text format     Related articles   


  47. WITEK RP , Stone WC, Karaca FG, Syn WK, et al
    Pan-caspase inhibitor VX-166 reduces fibrosis in an animal model of nonalcoholic steatohepatitis.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available


  48. OMENETTI A , Syn WK, Jung Y, Francis H, et al
    Repair-related activation of hedgehog signaling promotes cholangiocyte chemokine production.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available


  49. PATSENKER E , Popov Y, Stickel F, Schneider V, et al
    Pharmacological inhibition of integrin alphavbeta3 aggravates experimental liver fibrosis and suppresses hepatic angiogenesis.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available


  50. WENG HL , Liu Y, Chen JL, Huang T, et al
    The etiology of liver damage imparts cytokines transforming growth factor beta1 or interleukin-13 as driving forces in fibrogenesis.
    Hepatology. 2009;50:230-43.
    PubMed     Text format     Related articles    Abstract available


    June 2009
  51. MCNALLY RJ , Ducker S, James OF
    Are transient environmental agents involved in the cause of primary biliary cirrhosis? Evidence from space-time clustering analysis.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available


  52. LO GH
    The management of cirrhotic ascites.
    Hepatology. 2009;50:1320.
    PubMed     Text format     Related articles   


  53. HUNG TM , Chang SC, Yu WH, Wang YW, et al
    A novel nonsynonymous variant of matrix metalloproteinase-7 confers risk of liver cirrhosis.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available


  54. MACIAS J , Berenguer J, Japon MA, Giron JA, et al
    Fast fibrosis progression between repeated liver biopsies in patients coinfected with human immunodeficiency virus/hepatitis C virus.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available


  55. CARTER-KENT C , Yerian LM, Brunt EM, Angulo P, et al
    Nonalcoholic steatohepatitis in children: A multicenter clinicopathological study.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available


  56. YOSHIDA K , Yang GX, Zhang W, Tsuda M, et al
    Deletion of interleukin-12p40 suppresses autoimmune cholangitis in dominant negative transforming growth factor beta receptor type II mice.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available


  57. BAJAJ JS , Saeian K, Schubert CM, Hafeezullah M, et al
    Minimal hepatic encephalopathy is associated with motor vehicle crashes: The reality beyond the driving test.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available


  58. MARCOLONGO M , Young B, Dal Pero F, Fattovich G, et al
    A seven-gene signature (cirrhosis risk score) predicts liver fibrosis progression in patients with initially mild chronic hepatitis C.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available


  59. MILNER KL , van der Poorten D, Xu A, Bugianesi E, et al
    Adipocyte fatty acid binding protein levels relate to inflammation and fibrosis in nonalcoholic fatty liver disease.
    Hepatology. 2009;49:1926-34.
    PubMed     Text format     Related articles    Abstract available


    May 2009
  60. CAVAZZA A , Caballeria L, Floreani A, Farinati F, et al
    Incidence, risk factors, and survival of hepatocellular carcinoma in primary biliary cirrhosis: Comparative analysis from two centers.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available


  61. TONG Z , Chen R, Alt DS, Kemper S, et al
    Susceptibility to liver fibrosis in mice expressing a connective tissue growth factor transgene in hepatocytes.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available


  62. KIM H , Oh BK, Roncalli M, Park C, et al
    Large liver cell change in hepatitis B virus-related liver cirrhosis.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available


  63. RIMOLA J , Forner A, Reig M, Vilana R, et al
    Cholangiocarcinoma in cirrhosis: Absence of contrast washout in delayed phases by magnetic resonance imaging avoids misdiagnosis of hepatocellular carcinoma.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available


  64. TOY M , Veldhuijzen IK, de Man RA, Richardus JH, et al
    Potential impact of long-term nucleoside therapy on the mortality and morbidity of active chronic hepatitis B.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available


  65. LEI RX , Shi H, Peng XM, Zhu YH, et al
    Influence of a single nucleotide polymorphism in the P1 promoter of the furin gene on transcription activity and hepatitis B virus infection.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available


  66. DELEVE LD , Valla DC, Garcia-Tsao G
    Vascular disorders of the liver.
    Hepatology. 2009;49:1729-64.
    PubMed     Text format     Related articles   


  67. PARK O , Jeong WI, Wang L, Wang H, et al
    Diverse roles of invariant natural killer T cells in liver injury and fibrosis induced by carbon tetrachloride.
    Hepatology. 2009;49:1683-94.
    PubMed     Text format     Related articles    Abstract available


    April 2009
  68. DEGERTEKIN B , Lok AS
    Indications for therapy in hepatitis B.
    Hepatology. 2009;49.
    PubMed     Text format     Related articles    Abstract available


  69. MCMAHON BJ
    The natural history of chronic hepatitis B virus infection.
    Hepatology. 2009;49.
    PubMed     Text format     Related articles    Abstract available


  70. ZHONG B , Strnad P, Selmi C, Invernizzi P, et al
    Keratin variants are overrepresented in primary biliary cirrhosis and associate with disease severity.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available


  71. CRAWFORD DH , Ramm GA
    Reply: Utility of platelets and aspartate aminotransferase vs serum ferritin and serum hyaluronic acid as markers of cirrhosis in hemochromatosis.
    Hepatology. 2009;49:1781-1782.
    PubMed     Text format     Related articles   


  72. CASTIELLA A , Zapata E, Otazua P
    Hemochromatosis: Platelets and aspartate aminotransferase are useful high-degree fibrosis marker.
    Hepatology. 2009;49:1781.
    PubMed     Text format     Related articles   


  73. FUJITA T
    How does bacterial DNA induce liver failure in cirrhosis?
    Hepatology. 2009;49:1393.
    PubMed     Text format     Related articles   


  74. GHANY MG , Strader DB, Thomas DL, Seeff LB, et al
    Diagnosis, management, and treatment of hepatitis C: an update.
    Hepatology. 2009;49:1335-74.
    PubMed     Text format     Related articles   


  75. SHAH VH , Bruix J
    Antiangiogenic therapy: not just for cancer anymore?
    Hepatology. 2009;49:1066-8.
    PubMed     Text format     Related articles   


    March 2009
  76. DOGRU T , Ercin CN, Tapan S, Polat Z, et al
    Insulin resistance in prediction of esophageal varices.
    Hepatology. 2009.
    PubMed     Text format     Related articles   


  77. LI X , Wu K, Fan D
    Insulin resistance and platelet count/spleen diameter ratio: Two simple, easy-to-get tests for predicting esophageal varices in cirrhosis.
    Hepatology. 2009;49:1394.
    PubMed     Text format     Related articles   


  78. KAPLAN MM , Poupon R
    Treatment with immunosuppressives in patients with primary biliary cirrhosis who fail to respond to ursodiol.
    Hepatology. 2009.
    PubMed     Text format     Related articles   


  79. KARLMARK KR , Weiskirchen R, Zimmermann HW, Gassler N, et al
    Hepatic recruitment of the inflammatory Gr1(+) monocyte subset upon liver injury promotes hepatic fibrosis.
    Hepatology. 2009;50:261-274.
    PubMed     Text format     Related articles    Abstract available


  80. SEKI E , de Minicis S, Inokuchi S, Taura K, et al
    CCR2 promotes hepatic fibrosis in mice.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available


  81. IOANNOU GN , Morrow OB, Connole ML, Lee SP, et al
    Association between dietary nutrient composition and the incidence of cirrhosis or liver cancer in the united states population.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available


  82. ISABEL FIEL M , Schiano T
    An adolescent presenting with hematemesis and renal abnormalities.
    Hepatology. 2009;49:1050-1.
    PubMed     Text format     Related articles   


  83. YILMAZ Y , Ulukaya E, Dolar E
    The quest for liver fibrosis biomarkers: promises from the enhanced liver fibrosis panel and beyond.
    Hepatology. 2009;49:1056-7.
    PubMed     Text format     Related articles   


    February 2009
  84. JALAN R , Schnurr K, Mookerjee RP, Sen S, et al
    Alterations in the functional capacity of albumin in patients with decompensated cirrhosis is associated with increased mortality.
    Hepatology. 2009;50:555-564.
    PubMed     Text format     Related articles    Abstract available


  85. LINDOR KD , Gershwin ME, Poupon R, Kaplan M, et al
    Primary biliary cirrhosis.
    Hepatology. 2009;50:291-308.
    PubMed     Text format     Related articles   


  86. WANG XX , Song ZZ
    Insulin resistance is a risk factor for esophageal varices in hepatitis C virus cirrhosis.
    Hepatology. 2009;49:1775.
    PubMed     Text format     Related articles   


  87. DAVIES NA , Wright G, Ytrebo LM, Stadlbauer V, et al
    L-ornithine and phenylacetate synergistically produce sustained reduction in ammonia and brain water in cirrhotic rats.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available


  88. CLOUSTON AD , Jonsson JR, Powell EE
    Hepatic progenitor cell-mediated regeneration and fibrosis: Chicken or egg?
    Hepatology. 2009;49:1424-1426.
    PubMed     Text format     Related articles   


  89. HONG F , Tuyama A, Lee TF, Loke J, et al
    Hepatic stellate cells express functional CXCR4: Role in stromal cell-derived factor-1alpha-mediated stellate cell activation.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available


  90. LOK AS , Everhart JE, Chung RT, Kim HY, et al
    Evolution of hepatic steatosis in patients with advanced hepatitis C: Results from the hepatitis C antiviral long-term treatment against cirrhosis (HALT-C) trial.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available


  91. MAGEE JC
    Graft fibrosis in stable pediatric liver transplant recipients: What does it mean?
    Hepatology. 2009;49:726-728.
    PubMed     Text format     Related articles   


  92. WELZEL TM , Morgan TR, Bonkovsky HL, Naishadham D, et al
    Variants in interferon-alpha pathway genes and response to pegylated interferon-Alpha2a plus ribavirin for treatment of chronic hepatitis C virus infection in the hepatitis C antiviral long-term treatment against cirrhosis trial.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available


  93. MASUZAKI R , Tateishi R, Yoshida H, Goto E, et al
    Prospective risk assessment for hepatocellular carcinoma development in patients with chronic hepatitis C by transient elastography.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available


  94. SEBASTIANI G , Halfon P, Castera L, Pol S, et al
    SAFE biopsy: A validated method for large-scale staging of liver fibrosis in chronic hepatitis C.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available


  95. LEMMERS A , Moreno C, Gustot T, Marechal R, et al
    The interleukin-17 pathway is involved in human alcoholic liver disease.
    Hepatology. 2009;49:646-57.
    PubMed     Text format     Related articles    Abstract available


  96. YILMAZ Y , Ozdogan O
    Liver disease as a risk factor for cognitive decline and dementia: an under-recognized issue.
    Hepatology. 2009;49:698.
    PubMed     Text format     Related articles   


  97. INGILIZ P , Valantin MA, Duvivier C, Medja F, et al
    Liver damage underlying unexplained transaminase elevation in human immunodeficiency virus-1 mono-infected patients on antiretroviral therapy.
    Hepatology. 2009;49:436-42.
    PubMed     Text format     Related articles    Abstract available


    January 2009
  98. LLEO A , Selmi C, Invernizzi P, Podda M, et al
    Apotopes and the biliary specificity of primary biliary cirrhosis.
    Hepatology. 2009.
    PubMed     Text format     Related articles    Abstract available


  99. RUNYON BA
    Management of adult patients with ascites due to cirrhosis: An update.
    Hepatology. 2009;49:2087-2107.
    PubMed     Text format     Related articles   


  100. SEO YS , Um SH, Jung ES, Yim HJ, et al
    Serum alanine aminotransferase level alone may not accurately represent necro-inflammation in patients with acute hepatitis.
    Hepatology. 2009;49:1053-1054.
    PubMed     Text format     Related articles   


  101. SONG ZZ
    Extrahepatic cholestasis and liver stiffness by transient elastography.
    Hepatology. 2009;49:1053.
    PubMed     Text format     Related articles   


  102. GUHA IN
    Back to the future with noninvasive biomarkers of liver fibrosis.
    Hepatology. 2009;49:9-11.
    PubMed     Text format     Related articles   


  103. ELINAV E , Ali M, Bruck R, Brazowski E, et al
    Competitive inhibition of leptin signaling results in amelioration of liver fibrosis through modulation of stellate cell function.
    Hepatology. 2009;49:278-86.
    PubMed     Text format     Related articles    Abstract available


  104. NAVEAU S , Gaude G, Asnacios A, Agostini H, et al
    Diagnostic and prognostic values of noninvasive biomarkers of fibrosis in patients with alcoholic liver disease.
    Hepatology. 2009;49:97-105.
    PubMed     Text format     Related articles    Abstract available


    December 2008
  105. MURATA M , Matsuzaki K, Yoshida K, Sekimoto G, et al
    Hepatitis B virus X protein shifts human hepatic transforming growth factor (TGF)-beta signaling from tumor suppression to oncogenesis in early chronic hepatitis B.
    Hepatology. 2008.
    PubMed     Text format     Related articles    Abstract available


  106. PARADIS V , Zalinski S, Chelbi E, Guedj N, et al
    Hepatocellular carcinomas in patients with metabolic syndrome often develop without significant liver fibrosis: A pathological analysis.
    Hepatology. 2008.
    PubMed     Text format     Related articles    Abstract available


  107. VELAYUDHAM A , Dolganiuc A, Ellis M, Petrasek J, et al
    VSL#3 probiotic treatment attenuates fibrosis without changes in steatohepatitis in a diet-induced nonalcoholic steatohepatitis model in mice.
    Hepatology. 2008.
    PubMed     Text format     Related articles    Abstract available


  108. FIEL MI , Schiano T
    Jaundice developing in a patient with hepatitis C 4 months after liver transplantation.
    Hepatology. 2008;49:695-696.
    PubMed     Text format     Related articles   


  109. MOLLEKEN C , Sitek B, Henkel C, Poschmann G, et al
    Detection of novel biomarkers of liver cirrhosis by proteomic analysis.
    Hepatology. 2008.
    PubMed     Text format     Related articles    Abstract available


  110. THALHEIMER U , Bosch J, Patch D, Burroughs A, et al
    Improved survival with nonselective beta blockers.
    Hepatology. 2008;48:2091-2.
    PubMed     Text format     Related articles   


  111. WALDEN HR , Kirby JA, Yeaman SJ, Gray J, et al
    Xenobiotic incorporation into pyruvate dehydrogenase complex can occur via the exogenous lipoylation pathway.
    Hepatology. 2008;48:1874-84.
    PubMed     Text format     Related articles    Abstract available


  112. LEBRAY P , Varnous S, Charlotte F, Varaut A, et al
    Liver stiffness is an unreliable marker of liver fibrosis in patients with cardiac insufficiency.
    Hepatology. 2008;48:2089.
    PubMed     Text format     Related articles   


  113. CUBERO FJ , Nieto N
    Ethanol and arachidonic acid synergize to activate Kupffer cells and modulate the fibrogenic response via tumor necrosis factor alpha, reduced glutathione, and transforming growth factor beta-dependent mechanisms.
    Hepatology. 2008;48:2027-39.
    PubMed     Text format     Related articles    Abstract available


    November 2008
  114. MEJIAS M , Garcia-Pras E, Tiani C, Miquel R, et al
    Beneficial effects of sorafenib on splanchnic, intrahepatic, and portocollateral circulations in portal hypertensive and cirrhotic rats.
    Hepatology. 2008.
    PubMed     Text format     Related articles    Abstract available


  115. MOLES A , Tarrats N, Fernandez-Checa JC, Mari M, et al
    Cathepsins B and D drive hepatic stellate cell proliferation and promote their fibrogenic potential.
    Hepatology. 2008.
    PubMed     Text format     Related articles    Abstract available


  116. WIESNER RH
    Is there disease progression in patients who are hepatitis C virus antibody-positive and hepatitis C virus RNA-seronegative?
    Hepatology. 2008;48:1734-1736.
    PubMed     Text format     Related articles   


  117. DE MINICIS S , Seki E, Oesterreicher C, Schnabl B, et al
    Reduced nicotinamide adenine dinucleotide phosphate oxidase mediates fibrotic and inflammatory effects of leptin on hepatic stellate cells.
    Hepatology. 2008;48:2016-2026.
    PubMed     Text format     Related articles    Abstract available


  118. LUCIDARME D , Foucher J, Le Bail B, Vergniol J, et al
    Factors of accuracy of transient elastography (fibroscan) for the diagnosis of liver fibrosis in chronic hepatitis C.
    Hepatology. 2008.
    PubMed     Text format     Related articles    Abstract available


  119. CALVARUSO V , Burroughs AK, Standish R, Manousou P, et al
    Computer-assisted image analysis of liver collagen: Relationship to ishak scoring and hepatic venous pressure gradient.
    Hepatology. 2008.
    PubMed     Text format     Related articles    Abstract available


  120. WALKER LJ , Newton J, Jones DE, Bassendine MF, et al
    Comment on biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis.
    Hepatology. 2008.
    PubMed     Text format     Related articles   


  121. GUO J , Loke J, Zheng F, Hong F, et al
    Functional linkage of cirrhosis-predictive single nucleotide polymorphisms of toll-like receptor 4 to hepatic stellate cell responses.
    Hepatology. 2008.
    PubMed     Text format     Related articles    Abstract available


    October 2008
  122. TACKE F , Weiskirchen R, Trautwein C
    Liver function critically determines serum retinol-binding protein 4 (RBP4) levels in patients with chronic liver disease and cirrhosis.
    Hepatology. 2008;48:1724-1725.
    PubMed     Text format     Related articles   


  123. DOGRU T , Ercin CN, Erdem G, Tasci I, et al
    Nonalcoholic steatohepatitis is frequently accompanied by metabolic diseases.
    Hepatology. 2008;48:1728.
    PubMed     Text format     Related articles   


  124. WASMUTH HE , Tag CG, Van de Leur E, Hellerbrand C, et al
    The marburg I variant (G534E) of the factor VII-activating protease determines liver fibrosis in hepatitis C infection by reduced proteolysis of platelet-derived growth factor BB.
    Hepatology. 2008.
    PubMed     Text format     Related articles    Abstract available


  125. SCHEENSTRA R , Peeters PM, Verkade HJ, Gouw AS, et al
    Graft fibrosis after pediatric liver transplantation: Ten years of follow-up.
    Hepatology. 2008.
    PubMed     Text format     Related articles    Abstract available


  126. KENDALL TJ , Hennedige S, Aucott RL, Hartland SN, et al
    p75 neurotrophin receptor signaling regulates hepatic myofibroblast proliferation and apoptosis in recovery from rodent liver fibrosis.
    Hepatology. 2008.
    PubMed     Text format     Related articles    Abstract available


  127. ARAM G , Potter JJ, Liu X, Wang L, et al
    Deficiency of nicotinamide adenine dinucleotide phosphate, reduced form oxidase enhances hepatocellular injury but attenuates fibrosis after chronic carbon tetrachloride administration.
    Hepatology. 2008.
    PubMed     Text format     Related articles    Abstract available


  128. HAGIST S , Sultmann H, Millonig G, Hebling U, et al
    In vitro-targeted gene identification in patients with hepatitis C using a genome-wide microarray technology.
    Hepatology. 2008;49:378-386.
    PubMed     Text format     Related articles    Abstract available


  129. MYERS RP , Quan H, Hubbard JN, Shaheen AA, et al
    Predicting in-hospital mortality in patients with cirrhosis: Results differ across risk adjustment methods.
    Hepatology. 2008.
    PubMed     Text format     Related articles    Abstract available


  130. SONG ZZ
    Re: Transient elastography is unreliable for detection of cirrhosis in patients with acute liver damage.
    Hepatology. 2008;48:1351-2.
    PubMed     Text format     Related articles   


  131. CHEN TH , Chiu SY
    Re: Diabetes mellitus, chronic hepatitis C, and hepatocellular carcinoma.
    Hepatology. 2008;48:1348-9.
    PubMed     Text format     Related articles   


  132. SHAWCROSS DL , Wright GA, Stadlbauer V, Hodges SJ, et al
    Ammonia impairs neutrophil phagocytic function in liver disease.
    Hepatology. 2008;48:1202-12.
    PubMed     Text format     Related articles    Abstract available


  133. PERUGORRIA MJ , Latasa MU, Nicou A, Cartagena-Lirola H, et al
    The epidermal growth factor receptor ligand amphiregulin participates in the development of mouse liver fibrosis.
    Hepatology. 2008;48:1251-61.
    PubMed     Text format     Related articles    Abstract available


  134. BARASH H , Gross E, Edrei Y, Pappo O, et al
    Functional magnetic resonance imaging monitoring of pathological changes in rodent livers during hyperoxia and hypercapnia.
    Hepatology. 2008;48:1232-41.
    PubMed     Text format     Related articles    Abstract available


    September 2008
  135. CAMMA C , Petta S, Di Marco V, Bronte F, et al
    Insulin resistance is a risk factor for esophageal varices in hepatitis C virus cirrhosis.
    Hepatology. 2008.
    PubMed     Text format     Related articles    Abstract available


  136. PRINCIPE A , Melgar-Lesmes P, Fernandez-Varo G, Del Arbol LR, et al
    The hepatic apelin system: A new therapeutic target for liver disease.
    Hepatology. 2008.
    PubMed     Text format     Related articles    Abstract available


  137. CRAWFORD DH , Murphy TL, Ramm LE, Fletcher LM, et al
    Serum hyaluronic acid with serum ferritin accurately predicts cirrhosis and reduces the need for liver biopsy in C282Y hemochromatosis.
    Hepatology. 2008;49:418-425.
    PubMed     Text format     Related articles    Abstract available


  138. ZHANG W , Sharma R, Ju ST, He XS, et al
    Deficiency in regulatory T cells results in development of antimitochondrial antibodies and autoimmune cholangitis.
    Hepatology. 2008.
    PubMed     Text format     Related articles    Abstract available


  139. ZHONG YD , Yang YF
    Diabetes mellitus, chronic hepatitis C, and hepatocellular carcinoma.
    Hepatology. 2008.
    PubMed     Text format     Related articles   


  140. GARCIA-TSAO G , Parikh CR, Viola A
    Acute kidney injury in cirrhosis.
    Hepatology. 2008.
    PubMed     Text format     Related articles    Abstract available


  141. VUPPALANCHI R , Chalasani N
    Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis: Selected practical issues in their evaluation and management.
    Hepatology. 2008.
    PubMed     Text format     Related articles    Abstract available


  142. FRACANZANI AL , Valenti L, Bugianesi E, Andreoletti M, et al
    Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes.
    Hepatology. 2008;48:792-8.
    PubMed     Text format     Related articles    Abstract available


    August 2008
  143. MILLONIG G , Reimann FM, Friedrich S, Fonouni H, et al
    Extrahepatic cholestasis increases liver stiffness (FibroScan) irrespective of fibrosis.
    Hepatology. 2008.
    PubMed     Text format     Related articles    Abstract available


  144. GALBOIS A , Thabut D, Tazi KA, Rudler M, et al
    Ex vivo effects of high-density lipoprotein exposure on the lipopolysaccharide-induced inflammatory response in patients with severe cirrhosis.
    Hepatology. 2008.
    PubMed     Text format     Related articles    Abstract available


  145. INVERNIZZI P , Selmi C, Poli F, Frison S, et al
    Human leukocyte antigen polymorphisms in italian primary biliary cirrhosis: A multicenter study of 664 patients and 1992 healthy controls.
    Hepatology. 2008.
    PubMed     Text format     Related articles    Abstract available


  146. ZAPATER P , Frances R, Gonzalez-Navajas JM, de la Hoz MA, et al
    Serum and ascitic fluid bacterial DNA: A new independent prognostic factor in noninfected patients with cirrhosis.
    Hepatology. 2008.
    PubMed     Text format     Related articles    Abstract available


  147. MARHENKE S , Lamle J, Buitrago-Molina LE, Canon JM, et al
    Activation of nuclear factor E2-related factor 2 in hereditary tyrosinemia type 1 and its role in survival and tumor development.
    Hepatology. 2008;48:487-96.
    PubMed     Text format     Related articles    Abstract available


  148. MANNELLO F , Jung K
    Blood sampling affects circulating TIMP-1 concentration, a useful biomarker in estimating liver fibrosis stages.
    Hepatology. 2008;48:688-9.
    PubMed     Text format     Related articles   


    July 2008
  149. KALAMBOKIS GN , Tsianos EV
    Vasoconstrictor therapy for patients with cirrhosis with ascites but without hepatorenal syndrome.
    Hepatology. 2008;48:686.
    PubMed     Text format     Related articles   


  150. BANARES R , Albillos A, Catalina MV
    Which is the best way to analyze the efficacy of albumin dialysis in hepatic encephalopathy?
    Hepatology. 2008;48:686-687.
    PubMed     Text format     Related articles   


  151. CEOLOTTO G , Papparella I, Sticca A, Bova S, et al
    An abnormal gene expression of the beta-adrenergic system contributes to the pathogenesis of cardiomyopathy in cirrhotic rats.
    Hepatology. 2008.
    PubMed     Text format     Related articles    Abstract available


  152. JONES DE , Palmer JM, Burt AD, Kirby JA, et al
    The specificity of liver inflammation in mouse models of primary biliary cirrhosis.
    Hepatology. 2008.
    PubMed     Text format     Related articles   


  153. TAN JA , Joseph TA, Saab S
    Treating hepatitis C in the prison population is cost-saving.
    Hepatology. 2008.
    PubMed     Text format     Related articles    Abstract available


  154. MAYO MJ , Parkes J, Adams-Huet B, Combes B, et al
    Prediction of clinical outcomes in primary biliary cirrhosis by serum enhanced liver fibrosis assay.
    Hepatology. 2008.
    PubMed     Text format     Related articles    Abstract available


  155. MORISHIMA C , Morgan TR, Everhart JE, Wright EC, et al
    Interpretation of positive transcription-mediated amplification test results from polymerase chain reaction-negative samples obtained after treatment of chronic hepatitis C.
    Hepatology. 2008.
    PubMed     Text format     Related articles    Abstract available


  156. KAMATH PS
    The need for better clinical trials.
    Hepatology. 2008;48:1-3.
    PubMed     Text format     Related articles   


  157. MATSUMOTO A
    Management of gastric fundal varices.
    Hepatology. 2008;48:343-4.
    PubMed     Text format     Related articles   


    June 2008
  158. GOTTHARDT D , Runz H, Keitel V, Fischer C, et al
    A mutation in the canalicular phospholipid transporter gene, ABCB4, is associated with cholestasis, ductopenia, and cirrhosis in adults.
    Hepatology. 2008.
    PubMed     Text format     Related articles    Abstract available


  159. HOARE M , Gelson WT, Rushbrook SM, Curran MD, et al
    Histological changes in HCV antibody-positive, HCV RNA-negative subjects suggest persistent virus infection.
    Hepatology. 2008.
    PubMed     Text format     Related articles    Abstract available


  160. SILVEIRA MG , Suzuki A, Lindor KD
    Surveillance for hepatocellular carcinoma in patients with primary biliary cirrhosis.
    Hepatology. 2008.
    PubMed     Text format     Related articles    Abstract available


  161. TAKAHARA T , Xue F, Mazzone M, Yata Y, et al
    Metron factor-1 prevents liver injury without promoting tumor growth and metastasis.
    Hepatology. 2008;47:2010-25.
    PubMed     Text format     Related articles    Abstract available


    May 2008
  162. CORPECHOT C , Abenavoli L, Rabahi N, Chretien Y, et al
    Biochemical response to ursodeoxycholic acid and long-term prognosis in primary biliary cirrhosis.
    Hepatology. 2008;48:871-877.
    PubMed     Text format     Related articles    Abstract available


  163. BALAN V , Ruppert K, Demetris AJ, Ledneva T, et al
    Long-term outcome of human leukocyte antigen mismatching in liver transplantation: Results of the national institute of diabetes and digestive and kidney diseases liver transplantation database.
    Hepatology. 2008;48:878-888.
    PubMed     Text format     Related articles    Abstract available


  164. CATURELLI E , de Sio I
    Biopsy diagnosis of hepatocellular carcinoma.
    Hepatology. 2008;47:2145.
    PubMed     Text format     Related articles   


  165. PANOS G , Holmes P, Valero S, Anderson M, et al
    Transient elastography, liver stiffness values, and acute hepatopathy.
    Hepatology. 2008;47:2140.
    PubMed     Text format     Related articles   


  166. YEOMAN AD , Al-Chalabi T, Karani JB, Quaglia A, et al
    Evaluation of risk factors in the development of hepatocellular carcinoma in autoimmune hepatitis: Implications for follow-up and screening.
    Hepatology. 2008;48:863-870.
    PubMed     Text format     Related articles    Abstract available


  167. GINES P , Guevara M
    Hyponatremia in cirrhosis: Pathogenesis, clinical significance, and management.
    Hepatology. 2008.
    PubMed     Text format     Related articles    Abstract available


  168. MUHANNA N , Doron S, Wald O, Horani A, et al
    Activation of hepatic stellate cells after phagocytosis of lymphocytes: A novel pathway of fibrogenesis.
    Hepatology. 2008;48:963-977.
    PubMed     Text format     Related articles    Abstract available


  169. NITTA T , Kim JS, Mohuczy D, Behrns KE, et al
    Murine cirrhosis induces hepatocyte epithelial mesenchymal transition and alterations in survival signaling pathways.
    Hepatology. 2008.
    PubMed     Text format     Related articles    Abstract available


  170. CUA IH , Hui JM, Kench JG, George J, et al
    Genotype-specific interactions of insulin resistance, steatosis, and fibrosis in chronic hepatitis C.
    Hepatology. 2008.
    PubMed     Text format     Related articles    Abstract available


  171. VALENTI L , Dongiovanni P, Fracanzani AL, Fargion S, et al
    HFE mutations in nonalcoholic fatty liver disease.
    Hepatology. 2008;47:1794-5.
    PubMed     Text format     Related articles   


  172. IWAKIRI Y , Grisham M, Shah V
    Vascular biology and pathobiology of the liver: Report of a single-topic symposium.
    Hepatology. 2008;47:1754-63.
    PubMed     Text format     Related articles    Abstract available


    April 2008
  173. OHISHI Y , Nakamura M, Iio N, Higa S, et al
    Single-nucleotide polymorphism analysis of the multidrug resistance protein 3 gene for the detection of clinical progression in Japanese patients with primary biliary cirrhosis.
    Hepatology. 2008.
    PubMed     Text format     Related articles    Abstract available


  174. NOBILI V , Vizzutti F, Arena U, Abraldes JG, et al
    Accuracy and reproducibility of transient elastography for the diagnosis of fibrosis in pediatric nonalcoholic steatohepatitis.
    Hepatology. 2008;.
    PubMed     Text format     Related articles    Abstract available


  175. THEIN HH , Yi Q, Dore GJ, Krahn MD, et al
    Estimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: A meta-analysis and meta-regression.
    Hepatology. 2008;.
    PubMed     Text format     Related articles    Abstract available


  176. NEWTON JL , Hollingsworth KG, Taylor R, El-Sharkawy AM, et al
    Cognitive impairment in primary biliary cirrhosis: Symptom impact and potential etiology.
    Hepatology. 2008;.
    PubMed     Text format     Related articles    Abstract available


  177. PLANK LD , Gane EJ, Peng S, Muthu C, et al
    Nocturnal nutritional supplementation improves total body protein status of patients with liver cirrhosis: A randomized 12-month trial.
    Hepatology. 2008;.
    PubMed     Text format     Related articles    Abstract available


  178. SONG ZZ
    Diagnosis of hepatic nodules 20 mm or smaller in cirrhosis: Prospective validation of the noninvasive diagnostic criteria for hepatocellular carcinoma.
    Hepatology. 2008;47:2145-2146.
    PubMed     Text format     Related articles   


  179. VAN DER POORTEN D , Milner KL, Hui J, Hodge A, et al
    Visceral fat: A key mediator of steatohepatitis in metabolic liver disease.
    Hepatology. 2008;.
    PubMed     Text format     Related articles    Abstract available


  180. CHO YK , Kim JK
    Sustained complete response and low complication rates after radiofrequency ablation of very early hepatocellular carcinoma in cirrhosis.
    Hepatology. 2008;.
    PubMed     Text format     Related articles   


  181. CHARLTON M
    Cirrhosis and liver failure in nonalcoholic fatty liver disease: Molehill or mountain?
    Hepatology. 2008;.
    PubMed     Text format     Related articles   


  182. VALLA DC
    Thrombosis and anticoagulation in liver disease.
    Hepatology. 2008;47:1384-93.
    PubMed     Text format     Related articles   


    March 2008
  183. SASAKI M , Ikeda H, Yamaguchi J, Nakada S, et al
    Telomere shortening in the damaged small bile ducts in primary biliary cirrhosis reflects ongoing cellular senescence.
    Hepatology. 2008;.
    PubMed     Text format     Related articles    Abstract available


  184. HANNIVOORT RA , Dunning S, Vander Borght S, Schroyen B, et al
    Multidrug resistance-Associated proteins are crucial for the viability of activated rat hepatic stellate cells.
    Hepatology. 2008;.
    PubMed     Text format     Related articles    Abstract available


  185. JEPSEN P , Vilstrup H, Andersen PK, Lash TL, et al
    Comorbidity and survival of Danish cirrhosis patients: A nationwide population-based cohort study.
    Hepatology. 2008;.
    PubMed     Text format     Related articles    Abstract available


  186. ZEKRY A , Freiman J
    Eltrombopag: Is this "24 karat gold platelet" treatment for thrombocytopenia in cirrhosis associated with hepatitis C?
    Hepatology. 2008;47:1418-1421.
    PubMed     Text format     Related articles   


  187. TALWALKAR JA , Gossard AA
    Practice variation in treatment of primary biliary cirrhosis and effect on clinical outcomes.
    Hepatology. 2008;47:1428.
    PubMed     Text format     Related articles   


  188. UNO M , Kurita S, Misu H, Ando H, et al
    Tranilast, an antifibrogenic agent, ameliorates a dietary rat model of nonalcoholic steatohepatitis.
    Hepatology. 2008;48:109-118.
    PubMed     Text format     Related articles    Abstract available


  189. MYARA A , Guechot J, Lasnier E, Imbert-Bismut F, et al
    The use of enzyme results for liver fibrosis evaluation neccessitates standardization.
    Hepatology. 2008;47:1100-1.
    PubMed     Text format     Related articles   


    February 2008
  190. PALMA DT , Philips GM, Arguedas MR, Harding SM, et al
    Oxygen desaturation during sleep in hepatopulmonary syndrome.
    Hepatology. 2008;.
    PubMed     Text format     Related articles    Abstract available


  191. TRIPODI A
    How to implement the modified international normalized ratio for cirrhosis (INR(liver)) for model for end-stage liver disease calculation.
    Hepatology. 2008;.
    PubMed     Text format     Related articles   


  192. FRANCES R , Zapater P, Gonzalez-Navajas JM, Munoz C, et al
    Bacterial DNA in patients with cirrhosis and noninfected ascites mimics the soluble immune response established in patients with spontaneous bacterial peritonitis.
    Hepatology. 2008;47:978-985.
    PubMed     Text format     Related articles    Abstract available


  193. GINES P , Wong F, Watson H, Milutinovic S, et al
    Effects of satavaptan, a selective vasopressin V(2) receptor antagonist, on ascites and serum sodium in cirrhosis with hyponatremia: A randomized trial.
    Hepatology. 2008;.
    PubMed     Text format     Related articles    Abstract available


  194. ARAM G , Potter JJ, Liu X, Torbenson MS, et al
    Lack of inducible nitric oxide synthase leads to increased hepatic apoptosis and decreased fibrosis in mice after chronic carbon tetrachloride administration.
    Hepatology. 2008;47:2051-2058.
    PubMed     Text format     Related articles    Abstract available


  195. MARTIN-VILCHEZ S , Sanz-Cameno P, Rodriguez-Munoz Y, Majano PL, et al
    The hepatitis B virus X protein induces paracrine activation of human hepatic stellate cells.
    Hepatology. 2008;.
    PubMed     Text format     Related articles    Abstract available


  196. CHARLTON M , Angulo P, Chalasani N, Merriman R, et al
    Low circulating levels of dehydroepiandrosterone in histologically advanced nonalcoholic fatty liver disease.
    Hepatology. 2008;47:484-92.
    PubMed     Text format     Related articles    Abstract available


  197. VELDT BJ , Chen W, Heathcote EJ, Wedemeyer H, et al
    Increased risk of hepatocellular carcinoma among patients with hepatitis C cirrhosis and diabetes mellitus.
    Hepatology. 2008;47:1856-1862.
    PubMed     Text format     Related articles    Abstract available


    January 2008
  198. ADLER M , Gulbis B, Moreno C, Evrard S, et al
    The predictive value of FIB-4 versus FibroTest, APRI, FibroIndex and Forns index to noninvasively estimate fibrosis in hepatitis C and nonhepatitis C liver diseases.
    Hepatology. 2008;47:762-763.
    PubMed     Text format     Related articles   


  199. COBBOLD JF , Taylor-Robinson SD
    Transient elastography in acute hepatitis: All that's stiff is not fibrosis.
    Hepatology. 2008;47:370-372.
    PubMed     Text format     Related articles   


  200. YANG GX , Lian ZX, Chuang YH, Moritoki Y, et al
    Adoptive transfer of CD8(+) T cells from transforming growth factor beta receptor type II (dominant negative form) induces autoimmune cholangitis in mice.
    Hepatology. 2008;.
    PubMed     Text format     Related articles    Abstract available


  201. DE FRANCHIS R , Eisen GM, Laine L, Fernandez-Urien I, et al
    Esophageal capsule endoscopy for screening and surveillance of esophageal varices in patients with portal hypertension.
    Hepatology. 2008;47:1595-1603.
    PubMed     Text format     Related articles    Abstract available


  202. PERRI RE , Chiorean MV, Fidler JL, Fletcher JG, et al
    A prospective evaluation of computerized tomographic (CT) scanning as a screening modality for esophageal varices.
    Hepatology. 2008;.
    PubMed     Text format     Related articles    Abstract available


  203. BOSCH J , Thabut D, Albillos A, Carbonell N, et al
    Recombinant factor VIIa for variceal bleeding in patients with advanced cirrhosis: A randomized, controlled trial.
    Hepatology. 2008;.
    PubMed     Text format     Related articles    Abstract available


  204. KAHRAMAN A , Barreyro FJ, Bronk SF, Werneburg NW, et al
    TRAIL mediates liver injury by the innate immune system in the bile duct-ligated mouse.
    Hepatology. 2008;.
    PubMed     Text format     Related articles    Abstract available


  205. SHIMODA S , Harada K, Niiro H, Yoshizumi T, et al
    Biliary epithelial cells and primary biliary cirrhosis: The role of liver-infiltrating mononuclear cells.
    Hepatology. 2008;.
    PubMed     Text format     Related articles    Abstract available


  206. FONTANA RJ , Goodman ZD, Dienstag JL, Bonkovsky HL, et al
    Relationship of serum fibrosis markers with liver fibrosis stage and collagen content in patients with advanced chronic hepatitis C.
    Hepatology. 2008;.
    PubMed     Text format     Related articles    Abstract available


  207. TALWALKAR JA , Yin M, Fidler JL, Sanderson SO, et al
    Magnetic resonance imaging of hepatic fibrosis: emerging clinical applications.
    Hepatology. 2008;47:332-42.
    PubMed     Text format     Related articles    Abstract available


  208. KUROSAKI M , Izumi N
    External validation of FIB-4: diagnostic accuracy is limited in elderly populations.
    Hepatology. 2008;47:352.
    PubMed     Text format     Related articles   


  209. MORRA R , Lebray P, Ingiliz P, Ngo Y, et al
    FibroTest has better diagnostic and prognostic values than the aspartate aminotransferase-to-platelet ratio index in patients with chronic hepatitis C.
    Hepatology. 2008;47:353-4.
    PubMed     Text format     Related articles   


    December 2007
  210. DISTRUTTI E , Mencarelli A, Santucci L, Renga B, et al
    The methionine connection: Homocysteine and hydrogen sulfide exert opposite effects on hepatic microcirculation in rats.
    Hepatology. 2007;.
    PubMed     Text format     Related articles    Abstract available


  211. ROMERO-GOMEZ M , Gomez-Gonzalez E, Madrazo A, Vera-Valencia M, et al
    Optical analysis of computed tomography images of the liver predicts fibrosis stage and distribution in chronic hepatitis C.
    Hepatology. 2007;.
    PubMed     Text format     Related articles    Abstract available


  212. FUJITA T
    Beneficial effects of high-density lipoprotein administration on endotoxemia in an animal model of biliary cirrhosis.
    Hepatology. 2007;47:1099-1100.
    PubMed     Text format     Related articles   


  213. TREBICKA J , Leifeld L, Hennenberg M, Biecker E, et al
    Hemodynamic effects of urotensin II and its specific receptor antagonist palosuran in cirrhotic rats.
    Hepatology. 2007;.
    PubMed     Text format     Related articles    Abstract available


  214. ARENA U , Vizzutti F, Corti G, Ambu S, et al
    Acute viral hepatitis increases liver stiffness values measured by transient elastography.
    Hepatology. 2007;.
    PubMed     Text format     Related articles    Abstract available


  215. MARTINEZ-CHANTAR ML , Vazquez-Chantada M, Ariz U, Martinez N, et al
    Loss of the glycine N-methyltransferase gene leads to steatosis and hepatocellular carcinoma in mice.
    Hepatology. 2007;.
    PubMed     Text format     Related articles    Abstract available


  216. MENDES FD , Kim WR, Pedersen R, Therneau T, et al
    Mortality attributable to cholestatic liver disease in the United States.
    Hepatology. 2007;.
    PubMed     Text format     Related articles    Abstract available


  217. REYNOLDS GM , Harris HJ, Jennings A, Hu K, et al
    Hepatitis C virus receptor expression in normal and diseased liver tissue.
    Hepatology. 2007;.
    PubMed     Text format     Related articles    Abstract available


  218. GRACIA-SANCHO J , Lavina B, Rodriguez-Vilarrupla A, Garcia-Caldero H, et al
    Increased oxidative stress in cirrhotic rat livers: A potential mechanism contributing to reduced nitric oxide bioavailability.
    Hepatology. 2007;.
    PubMed     Text format     Related articles    Abstract available


    November 2007
  219. KULIK LM , Carr BI, Mulcahy MF, Lewandowski RJ, et al
    Safety and efficacy of (90)Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis.
    Hepatology. 2007;.
    PubMed     Text format     Related articles    Abstract available


  220. YAMAGUCHI K , Yang L, McCall S, Huang J, et al
    Diacylglycerol acyltranferase 1 anti-sense oligonucleotides reduce hepatic fibrosis in mice with nonalcoholic steatohepatitis.
    Hepatology. 2007;.
    PubMed     Text format     Related articles    Abstract available


    October 2007
  221. SOBESKY R , Feray C, Rimlinger F, Derian N, et al
    Distinct hepatitis C virus core and F protein quasispecies in tumoral and nontumoral hepatocytes isolated via microdissection.
    Hepatology. 2007;.
    PubMed     Text format     Related articles    Abstract available


    September 2007
  222. WONG F , Moore K, Dingemanse J, Jalan R, et al
    Lack of renal improvement with nonselective endothelin antagonism with tezosentan in type 2 hepatorenal syndrome.
    Hepatology. 2007;.
    PubMed     Text format     Related articles    Abstract available


    August 2007
  223. VERMA S , Torbenson M, Thuluvath PJ
    The impact of ethnicity on the natural history of autoimmune hepatitis.
    Hepatology. 2007;.
    PubMed     Text format     Related articles    Abstract available


Thank you for your interest in scientific medicine.


Amedeo is a Flying Publisher website.

   Design: